The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
Abstract
Share and Cite
Hassan, N.; Bückreiß, N.; Efing, J.; Schulz-Fincke, M.; König, P.; Greve, B.; Bendas, G.; Götte, M. The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor. Cells 2023, 12, 910. https://doi.org/10.3390/cells12060910
Hassan N, Bückreiß N, Efing J, Schulz-Fincke M, König P, Greve B, Bendas G, Götte M. The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor. Cells. 2023; 12(6):910. https://doi.org/10.3390/cells12060910
Chicago/Turabian StyleHassan, Nourhan, Nico Bückreiß, Janes Efing, Marie Schulz-Fincke, Philipp König, Burkhard Greve, Gerd Bendas, and Martin Götte. 2023. "The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor" Cells 12, no. 6: 910. https://doi.org/10.3390/cells12060910
APA StyleHassan, N., Bückreiß, N., Efing, J., Schulz-Fincke, M., König, P., Greve, B., Bendas, G., & Götte, M. (2023). The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor. Cells, 12(6), 910. https://doi.org/10.3390/cells12060910